|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Essential Axillary Hyperhidrosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hyperhidrosis | |||||
| 3 | More general conditions related to this trial | ||||
| Skin Diseases | |||||
| Sweat Gland Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Suction curettage | |||||
| Treatment with Botox | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Botulinum Toxin Type A | |||||
| 6 | More general drug interventions related to this trial | ||||
| Neuromuscular Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 7 | Sponsors listed in this trial | ||||
| University Hospital, Ghent | |||||
| Allergan | |||||